Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Herceptin|DRUG: Herceptin
Sponsor: Hoffmann-La Roche
Collaborators: Breast International Group|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|ETOP IBCSG Partners Foundation